{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T12:21:56Z","timestamp":1776774116892,"version":"3.51.2"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T00:00:00Z","timestamp":1362096000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Indian Pediatr"],"published-print":{"date-parts":[[2013,3]]},"DOI":"10.1007\/s13312-013-0098-9","type":"journal-article","created":{"date-parts":[[2013,3,27]],"date-time":"2013-03-27T10:44:37Z","timestamp":1364381077000},"page":"307-313","source":"Crossref","is-referenced-by-count":22,"title":["Propranolol therapy for infantile hemangioma"],"prefix":"10.1007","volume":"50","author":[{"given":"Nivedita","family":"Gunturi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sriram","family":"Ramgopal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Subramanian","family":"Balagopal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julius Xavier","family":"Scott","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,3,28]]},"reference":[{"key":"98_CR1","volume-title":"Proceedings of a Research Workshop on Infantile Hemangiomas; 2005 April 7\u20139","author":"IJ Frieden","year":"2005","unstructured":"Frieden IJ, Haggstrom AN, Drolet BA, Mancini AJ, Friedlander SF, Boon L, et al. Infantile hemangiomas: current knowledge, future directions. Proceedings of a Research Workshop on Infantile Hemangiomas; 2005 April 7\u20139; Bethesda, Maryland, USA. Hoboken: Wiley-Blackwell; 2005."},{"key":"98_CR2","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1016\/B978-072169347-7.50102-5","volume-title":"Avery\u2019s diseases of the newborn","author":"AZ Young","year":"2005","unstructured":"Young AZ, Cohen BA, Siegfried EC. Cutaneous Congenital Defects. In: Taeusch HW, Ballard RA, Gleason CA, Avery ME, editors. Avery\u2019s diseases of the newborn. 8th ed. Philadelphia: Elsevier Saunders; 2005. p. 1521\u20131538.","edition":"8th ed"},{"key":"98_CR3","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1111\/j.1365-2133.2009.09597.x","volume":"162","author":"F Manunza","year":"2010","unstructured":"Manunza F, Syed S, Laguda B, Linward J, Kennedy H, Gholam K, et al. Propranolol for complicated infantile haemangiomas: a case series of 30 infants. Br J Dermatol. 2010;162:466\u2013468.","journal-title":"Br J Dermatol."},{"key":"98_CR4","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1111\/j.1442-9071.2010.02344.x","volume":"38","author":"JF Cheng","year":"2010","unstructured":"Cheng JF, Gole GA, Sullivan TJ. Propranolol in the management of periorbital infantile haemangioma. Clin Experiment Ophthalmol. 2010;38:547\u2013553.","journal-title":"Clin Experiment Ophthalmol."},{"key":"98_CR5","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1016\/S0002-9440(10)63077-5","volume":"159","author":"Y Yu","year":"2001","unstructured":"Yu Y, Varughese J, Brown LF, Mulliken JB, Bischoff J. Increased Tie2 expression, enhanced response to angiopoietin-1, and dysregulated angiopoietin-2 expression in hemangioma-derived endothelial cells. Am J Pathol. 2001;159:2271\u20132280.","journal-title":"Am J Pathol."},{"key":"98_CR6","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1172\/JCI117241","volume":"93","author":"K Takahashi","year":"1994","unstructured":"Takahashi K, Mulliken JB, Kozakewich HP, Rogers RA, Folkman J, Ezekowitz RA. Cellular markers that distinguish the phases of hemangioma during infancy and childhood. J Clin Invest. 1994;93:2357\u20132364.","journal-title":"J Clin Invest."},{"key":"98_CR7","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0046-8177(00)80192-6","volume":"31","author":"PE North","year":"2000","unstructured":"North PE, Waner M, Mizeracki A, Mihm MC, Jr. GLUT1: a newly discovered immunohistochemical marker for juvenile hemangiomas. Hum Pathol. 2000;31:11\u201322.","journal-title":"Hum Pathol."},{"key":"98_CR8","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.1056\/NEJMc0708819","volume":"358","author":"C Leaute-Labreze","year":"2008","unstructured":"Leaute-Labreze C, Dumas de la Roque E, Hubiche T, Boralevi F, Thambo JB, Taieb A. Propranolol for severe hemangiomas of infancy. N Engl J Med. 2008;358: 2649\u20132651.","journal-title":"N Engl J Med."},{"key":"98_CR9","doi-asserted-by":"crossref","first-page":"e259","DOI":"10.1542\/peds.2010-0029","volume":"128","author":"M Hogeling","year":"2011","unstructured":"Hogeling M, Adams S, Wargon O. A randomized controlled trial of propranolol for infantile hemangiomas. Pediatrics. 2011;128:e259\u2013e266.","journal-title":"Pediatrics."},{"key":"98_CR10","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1177\/0194599812451570","volume":"147","author":"MM Bingham","year":"2012","unstructured":"Bingham MM, Saltzman B, Vo NJ, Perkins JA. Propranolol reduces infantile hemangioma volume and vessel density. Otolaryngol Head Neck Surg. 2012;147:338\u2013344.","journal-title":"Otolaryngol Head Neck Surg."},{"key":"98_CR11","doi-asserted-by":"crossref","first-page":"a006460","DOI":"10.1101\/cshperspect.a006460","volume":"1","author":"S Greenberger","year":"2011","unstructured":"Greenberger S, Bischoff J. Infantile Hemangioma-Mechanism(s) of Drug Action on a Vascular Tumor. Cold Spring Harb Perspect Med. 2011;1:a006460.","journal-title":"Cold Spring Harb Perspect Med."},{"key":"98_CR12","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1161\/01.RES.84.12.1407","volume":"84","author":"S Egert","year":"1999","unstructured":"Egert S, Nguyen N, Schwaiger M. Contribution of alphaadrenergic and beta-adrenergic stimulation to ischemiainduced glucose transporter (GLUT) 4 and GLUT1 translocation in the isolated perfused rat heart. Circ Res. 1999;84:1407\u20131415.","journal-title":"Circ Res."},{"key":"98_CR13","doi-asserted-by":"crossref","first-page":"e423","DOI":"10.1542\/peds.2008-3458","volume":"124","author":"V Sans","year":"2009","unstructured":"Sans V, de la Roque ED, Berge J, Grenier N, Boralevi F, Mazereeuw-Hautier J, et al. Propranolol for severe infantile hemangiomas: follow-up report. Pediatrics. 2009;124:e423\u2013e431.","journal-title":"Pediatrics."},{"key":"98_CR14","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1111\/j.1525-1470.2010.01379.x","volume":"28","author":"A Zvulunov","year":"2011","unstructured":"Zvulunov A, McCuaig C, Frieden IJ, Mancini AJ, Puttgen KB, Dohil M, et al. Oral propranolol therapy for infantile hemangiomas beyond the proliferation phase: a multicenter retrospective study. Pediatr Dermatol. 2011;28:94\u201398.","journal-title":"Pediatr Dermatol."},{"key":"98_CR15","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1111\/j.1525-1470.2011.01345.x","volume":"28","author":"L Bagazgoitia","year":"2011","unstructured":"Bagazgoitia L, Torrelo A, Gutierrez JC, Hernandez-Martin A, Luna P, Gutierrez M, et al. Propranolol for infantile hemangiomas. Pediatr Dermatol. 2011;28:108\u2013114.","journal-title":"Pediatr Dermatol."},{"key":"98_CR16","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1002\/pbc.22262","volume":"54","author":"A Marsciani","year":"2010","unstructured":"Marsciani A, Pericoli R, Alaggio R, Brisigotti M, Vergine G. Massive response of severe infantile hepatic hemangioma to propanolol. Pediatr Blood Cancer. 2010;54:176.","journal-title":"Pediatr Blood Cancer."},{"key":"98_CR17","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1017\/S002221511000068X","volume":"124","author":"N Mistry","year":"2010","unstructured":"Mistry N, Tzifa K. Use of propranolol to treat multicentric airway haemangioma. J Laryngol Otol. 2010;124:1329\u20131332.","journal-title":"J Laryngol Otol."},{"key":"98_CR18","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.jaad.2011.01.025","volume":"64","author":"DJ Hermans","year":"2011","unstructured":"Hermans DJ, van Beynum IM, Schultze Kool LJ, van de Kerkhof PC, Wijnen MH, van der Vleuten CJ. Propranolol, a very promising treatment for ulceration in infantile hemangiomas: a study of 20 cases with matched historical controls. J Am Acad Dermatol. 2011;64:833\u2013838.","journal-title":"J Am Acad Dermatol."},{"key":"98_CR19","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1179\/146532810X12858955921393","volume":"30","author":"S Muthamilselvan","year":"2010","unstructured":"Muthamilselvan S, Vinoth PN, Vilvanathan V, Ninan B, Amboiram P, Sai V, et al. Hepatic haemangioma of infancy: role of propranolol. Ann Trop Paediatr. 2010;30:335\u2013338.","journal-title":"Ann Trop Paediatr."},{"key":"98_CR20","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1177\/0009922811405517","volume":"50","author":"J Blatt","year":"2011","unstructured":"Blatt J, Morrell DS, Buck S, Zdanski C, Gold S, Stavas J, et al. beta-blockers for infantile hemangiomas: a singleinstitution experience. Clin Pediatr (Phila). 2011;50:757\u2013763.","journal-title":"Clin Pediatr (Phila)."},{"key":"98_CR21","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.bjps.2010.07.009","volume":"64","author":"WJ Holmes","year":"2011","unstructured":"Holmes WJ, Mishra A, Gorst C, Liew SH. Propranolol as first-line treatment for rapidly proliferating infantile haemangiomas. J Plast Reconstr Aesthet Surg. 2011;64:445\u2013451.","journal-title":"J Plast Reconstr Aesthet Surg."},{"key":"98_CR22","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1001\/archdermatol.2011.203","volume":"147","author":"CJ Price","year":"2011","unstructured":"Price CJ, Lattouf C, Baum B, McLeod M, Schachner LA, Duarte AM, et al. Propranolol vs corticosteroids for infantile hemangiomas: a multicenter retrospective analysis. Arch Dermatol. 2011;147:1371\u20131376.","journal-title":"Arch Dermatol."},{"key":"98_CR23","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1111\/j.1468-3083.2011.04314.x","volume":"26","author":"J Rossler","year":"2012","unstructured":"Rossler J, Schill T, Bahr A, Truckenmuller W, Noellke P, Niemeyer CM. Propranolol for proliferating infantile haemangioma is superior to corticosteroid therapy \u2014 a retrospective, single centre study. J Eur Acad Dermatol Venereol. 2012;26:1173\u20131175.","journal-title":"J Eur Acad Dermatol Venereol."},{"key":"98_CR24","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1111\/j.1525-1470.2011.01569.x","volume":"28","author":"CJ Schupp","year":"2011","unstructured":"Schupp CJ, Kleber JB, Gunther P, Holland-Cunz S. Propranolol therapy in 55 infants with infantile hemangioma: dosage, duration, adverse effects, and outcome. Pediatr Dermatol. 2011;28:640\u2013644.","journal-title":"Pediatr Dermatol."},{"key":"98_CR25","first-page":"808","volume":"11","author":"A Celik","year":"2012","unstructured":"Celik A, Tiryaki S, Musayev A, Kismali E, Levent E, Ergun O. Propranolol as the first-line therapy for infantile hemangiomas: preliminary results of two centers. J Drugs Dermatol. 2012;11:808\u2013811.","journal-title":"J Drugs Dermatol."},{"key":"98_CR26","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/j.jaad.2010.12.040","volume":"64","author":"M Saint-Jean","year":"2011","unstructured":"Saint-Jean M, Leaute-Labreze C, Mazereeuw-Hautier J, Bodak N, Hamel-Teillac D, Kupfer-Bessaguet I, et al. Propranolol for treatment of ulcerated infantile hemangiomas. J Am Acad Dermatol. 2011;64:827\u2013832.","journal-title":"J Am Acad Dermatol."},{"key":"98_CR27","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.jpedsurg.2011.10.058","volume":"47","author":"AA Talaat","year":"2012","unstructured":"Talaat AA, Elbasiouny MS, Elgendy DS, Elwakil TF. Propranolol treatment of infantile hemangioma: clinical and radiologic evaluations. J Pediatr Surg. 2012;47:707\u2013714.","journal-title":"J Pediatr Surg."},{"key":"98_CR28","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1111\/j.1525-1470.2011.01551.x","volume":"28","author":"J Bertrand","year":"2011","unstructured":"Bertrand J, McCuaig C, Dubois J, Hatami A, Ondrejchak S, Powell J. Propranolol versus prednisone in the treatment of infantile hemangiomas: a retrospective comparative study. Pediatr Dermatol. 2011;28:649\u2013654.","journal-title":"Pediatr Dermatol."},{"key":"98_CR29","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.jpeds.2010.04.003","volume":"157","author":"J Mazereeuw-Hautier","year":"2010","unstructured":"Mazereeuw-Hautier J, Hoeger PH, Benlahrech S, Ammour A, Broue P, Vial J, et al. Efficacy of propranolol in hepatic infantile hemangiomas with diffuse neonatal hemangiomatosis. J Pediatr. 2010;157:340\u2013342.","journal-title":"J Pediatr."},{"key":"98_CR30","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1007\/s00431-010-1324-2","volume":"170","author":"C Schiestl","year":"2011","unstructured":"Schiestl C, Neuhaus K, Zoller S, Subotic U, Forster-Kuebler I, Michels R, et al. Efficacy and safety of propranolol as first-line treatment for infantile hemangiomas. Eur J Pediatr. 2011;170:493\u2013501.","journal-title":"Eur J Pediatr."},{"key":"98_CR31","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.ijporl.2010.05.013","volume":"74","author":"C Blanchet","year":"2010","unstructured":"Blanchet C, Nicollas R, Bigorre M, Amedro P, Mondain M. Management of infantile subglottic hemangioma: acebutolol or propranolol? Int J Pediatr Otorhinolaryngol. 2010;74:959\u2013961.","journal-title":"Int J Pediatr Otorhinolaryngol"},{"key":"98_CR32","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1159\/000291300","volume":"98","author":"A Vanlander","year":"2010","unstructured":"Vanlander A, Decaluwe W, Vandelanotte M, Van Geet C, Cornette L. Propranolol as a novel treatment for congenital visceral haemangioma. Neonatology. 2010;98:229\u2013231.","journal-title":"Neonatology."},{"key":"98_CR33","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1007\/s00381-010-1153-7","volume":"26","author":"DH Fulkerson","year":"2010","unstructured":"Fulkerson DH, Agim NG, Al-Shamy G, Metry DW, Izaddoost SA, Jea A. Emergent medical and surgical management of mediastinal infantile hemangioma with symptomatic spinal cord compression: case report and literature review. Childs Nerv Syst. 2010;26:1799\u20131805.","journal-title":"Childs Nerv Syst."},{"key":"98_CR34","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.jaapos.2010.05.002","volume":"14","author":"KM Haider","year":"2010","unstructured":"Haider KM, Plager DA, Neely DE, Eikenberry J, Haggstrom A. Outpatient treatment of periocular infantile hemangiomas with oral propranolol. J AAPOS. 2010;14:251\u2013256.","journal-title":"J AAPOS."},{"key":"98_CR35","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.anorl.2010.11.009","volume":"128","author":"N Leboulanger","year":"2011","unstructured":"Leboulanger N, Cox A, Garabedian EN, Denoyelle F. Infantile haemangioma and beta-blockers in otolaryngology. Eur Ann Otorhinolaryngol Head Neck Dis. 2011;128:236\u2013240.","journal-title":"Eur Ann Otorhinolaryngol Head Neck Dis."},{"key":"98_CR36","volume-title":"Eur J Pediatr Surg.","author":"S Hernandez-Martin","year":"2011","unstructured":"Hernandez-Martin S, Lopez-Gutierrez JC, Lopez-Fernandez S, Ramirez M, Miguel M, Coya J, et al. Brain Perfusion SPECT in Patients with PHACES Syndrome Under Propranolol Treatment. Eur J Pediatr Surg. 2011."},{"key":"98_CR37","doi-asserted-by":"crossref","first-page":"114","DOI":"10.4103\/0378-6323.90966","volume":"78","author":"S Mohanan","year":"2012","unstructured":"Mohanan S, Besra L, Chandrashekar L, Thappa DM. Excellent response of infantile hemangioma associated with PHACES syndrome to propranolol. Indian J Dermatol Venereol Leprol. 2012;78:114\u2013115.","journal-title":"Indian J Dermatol Venereol Leprol."},{"key":"98_CR38","volume-title":"Ann Plast Surg","author":"Q Chai","year":"2011","unstructured":"Chai Q, Chen WL, Huang ZQ, Zhang DM, Fan S, Wang L. Preliminary Experiences in Treating Infantile Hemangioma With Propranolol. Ann Plast Surg. 2011."},{"key":"98_CR39","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1001\/archdermatol.2010.158","volume":"146","author":"KE Holland","year":"2010","unstructured":"Holland KE, Frieden IJ, Frommelt PC, Mancini AJ, Wyatt D, Drolet BA. Hypoglycemia in children taking propranolol for the treatment of infantile hemangioma. Arch Dermatol. 2010;146:775\u2013778.","journal-title":"Arch Dermatol."},{"key":"98_CR40","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/j.1525-1470.2011.01615.x","volume":"29","author":"K Kunzi-Rapp","year":"2012","unstructured":"Kunzi-Rapp K. Topical propranolol therapy for infantile hemangiomas. Pediatr Dermatol. 2012;29:154\u2013159.","journal-title":"Pediatr Dermatol."},{"key":"98_CR41","volume-title":"Pediatr Dermatol.","author":"M Moehrle","year":"2012","unstructured":"Moehrle M, Leaute-Labreze C, Schmidt V, Rocken M, Poets CF, Goelz R. Topical Timolol for Small Hemangiomas of Infancy. Pediatr Dermatol. 2012."},{"key":"98_CR42","first-page":"450","volume":"52","author":"A Erbay","year":"2010","unstructured":"Erbay A, Sarialioglu F, Malbora B, Yildirim SV, Varan B, Tarcan A, et al. Propranolol for infantile hemangiomas: a preliminary report on efficacy and safety in very low birth weight infants. Turk J Pediatr. 2010;52:450\u2013456.","journal-title":"Turk J Pediatr."},{"key":"98_CR43","first-page":"161","volume":"28","author":"XX Ye","year":"2012","unstructured":"Ye XX, Jin YB, Lin XX, Ma G, Chen XD, Qiu YJ, et al. [Topical timolol in the treatment of periocular superficial infantile hemangiomas: a prospective study]. Zhonghua Zheng Xing Wai Ke Za Zhi. 2012;28:161\u2013164.","journal-title":"Zhonghua Zheng Xing Wai Ke Za Zhi"},{"key":"98_CR44","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1089\/jop.2011.0013","volume":"27","author":"AC Koay","year":"2011","unstructured":"Koay AC, Choo MM, Nathan AM, Omar A, Lim CT. Combined low-dose oral propranolol and oral prednisolone as first-line treatment in periocular infantile hemangiomas. J Ocul Pharmacol Ther. 2011;27:309\u2013311.","journal-title":"J Ocul Pharmacol Ther."},{"key":"98_CR45","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1001\/archoto.2010.92","volume":"136","author":"KW Rosbe","year":"2010","unstructured":"Rosbe KW, Suh KY, Meyer AK, Maguiness SM, Frieden IJ. Propranolol in the management of airway infantile hemangiomas. Arch Otolaryngol Head Neck Surg. 2010;136:658\u2013665.","journal-title":"Arch Otolaryngol Head Neck Surg."},{"key":"98_CR46","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1111\/j.1440-1754.2011.02387.x","volume":"47","author":"A Nunn","year":"2011","unstructured":"Nunn A, Shah U, Ford J. Giving propranolol tablets to infants with hemangiomas. J Paediatr Child Health. 2011;47:927.","journal-title":"J Paediatr Child Health."},{"key":"98_CR47","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.2147\/OPTH.S22909","volume":"5","author":"A Awadein","year":"2011","unstructured":"Awadein A, Fakhry MA. Evaluation of intralesional propranolol for periocular capillary hemangioma. Clin Ophthalmol. 2011;5:1135\u20131140.","journal-title":"Clin Ophthalmol."},{"key":"98_CR48","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1111\/j.1525-1470.2009.00975.x","volume":"26","author":"LP Lawley","year":"2009","unstructured":"Lawley LP, Siegfried E, Todd JL. Propranolol treatment for hemangioma of infancy: risks and recommendations. Pediatr Dermatol. 2009;26:610\u2013614.","journal-title":"Pediatr Dermatol."},{"key":"98_CR49","first-page":"3130","volume":"89","author":"ZP Qin","year":"2009","unstructured":"Qin ZP, Liu XJ, Li KL, Zhou Q, Yang XJ, Zheng JW. [Treatment of infantile hemangiomas with low-dose propranolol: evaluation of short-term efficacy and safety]. Zhonghua Yi Xue Za Zhi. 2009;89:3130\u20133134.","journal-title":"Zhonghua Yi Xue Za Zhi."},{"key":"98_CR50","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1002\/lary.20807","volume":"120","author":"LM Buckmiller","year":"2010","unstructured":"Buckmiller LM, Munson PD, Dyamenahalli U, Dai Y, Richter GT. Propranolol for infantile hemangiomas: early experience at a tertiary vascular anomalies center. Laryngoscope. 2010;120:676\u2013681.","journal-title":"Laryngoscope."}],"container-title":["Indian Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13312-013-0098-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13312-013-0098-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13312-013-0098-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T15:41:11Z","timestamp":1559490071000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13312-013-0098-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3]]},"references-count":50,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,3]]}},"alternative-id":["98"],"URL":"https:\/\/doi.org\/10.1007\/s13312-013-0098-9","relation":{},"ISSN":["0019-6061","0974-7559"],"issn-type":[{"value":"0019-6061","type":"print"},{"value":"0974-7559","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,3]]}}}